/
/
/

Aashka Hospitals Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
--4%-17%-1%
-19%11%39%
--4%10%0%
5%4%1%3%

Peer Comparison

Symbol
APOLLOHOSP-A
MAXHEALTH-A
FORTIS-A
ASTERDM-A
NH-A
MEDANTA-A
LALPATHLAB-A
KIMS-A
AGARWALEYE-A
VIJAYA-A
AASHKA-M
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
8,666.8₹126300 Cr60.4540.39207.67₹1942 Cr
990.5₹96763 Cr66.423.3119.84₹1442 Cr
911.95₹68901 Cr65.753.5320.1₹1042 Cr
789.8₹68592 Cr215.240.316.76₹464 Cr
1,866.55₹38439 Cr47.110.1465.36₹806 Cr
1,482.8₹38149 Cr68.595.9129.85₹556 Cr
1,876₹32259 Cr59.5310.1142.51₹505 Cr
765.3₹32231 Cr157.771.0412.74₹241 Cr
510.2₹16249 Cr109.521.4313.88₹133 Cr
1,494.45₹15511 Cr82.735.1627.53₹173 Cr
84.85₹199 Cr59.452.7₹3 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
₹23 Cr₹23 Cr₹23 Cr₹23 Cr₹18 Cr₹18 Cr₹17 Cr
₹76 Cr₹73 Cr₹71 Cr₹73 Cr₹11 Cr₹6 Cr-₹2 Cr
₹76 Cr₹73 Cr₹71 Cr₹73 Cr₹11 Cr₹6 Cr-₹2 Cr
₹100 Cr₹96 Cr₹94 Cr₹97 Cr₹29 Cr₹24 Cr₹15 Cr
₹5 Cr₹7 Cr₹13 Cr₹16 Cr₹20 Cr₹22 Cr₹24 Cr
₹50 L₹81 L₹3 Cr₹33 L₹1 L₹3 Cr₹26 L
₹50 L₹50 L₹50 L₹50 L₹50 L₹50 L₹98 L
₹24 L₹18 L₹20 L₹21 L₹13 L₹14 L₹17 L
₹7 Cr₹9 Cr₹17 Cr₹17 Cr₹21 Cr₹26 Cr₹26 Cr
₹89 L₹2 Cr₹3 Cr₹2 Cr₹4 Cr₹2 Cr₹3 Cr
₹4 Cr₹7 Cr₹8 Cr₹6 Cr₹8 Cr₹5 Cr₹9 Cr
₹4 Cr₹6 Cr₹6 Cr₹6 Cr₹2 Cr₹2 Cr₹1 Cr
₹1 Cr₹2 Cr₹97 L₹1 Cr₹99 L₹84 L₹42 L
₹10 Cr₹16 Cr₹17 Cr₹15 Cr₹15 Cr₹10 Cr₹13 Cr
₹116 Cr₹121 Cr₹128 Cr₹129 Cr₹65 Cr₹60 Cr₹54 Cr
₹13 Cr₹20 Cr₹29 Cr₹28 Cr₹28 Cr₹31 Cr₹33 Cr
₹67 Cr₹66 Cr₹66 Cr₹66 Cr₹64 Cr₹56 Cr₹56 Cr
₹26 Cr₹23 Cr₹20 Cr₹17 Cr₹14 Cr₹12 Cr₹9 Cr
₹41 Cr₹43 Cr₹45 Cr₹48 Cr₹49 Cr₹44 Cr₹46 Cr
₹88 L₹45 L₹5 L₹0₹0₹0₹8 L
₹62 Cr₹68 Cr₹69 Cr₹68 Cr₹2 Cr₹27 L₹24 L
₹103 Cr₹111 Cr₹114 Cr₹117 Cr₹51 Cr₹44 Cr₹47 Cr
₹40 L₹37 L₹40 L₹55 L₹54 L₹64 L₹46 L
₹5 Cr₹5 Cr₹7 Cr₹8 Cr₹7 Cr₹7 Cr₹3 Cr
₹3 Cr₹2 Cr₹3 Cr₹1 Cr₹3 Cr₹4 Cr₹1 Cr
₹23 L₹6 L₹11 L₹13 L₹15 L₹14 L₹20 L
₹5 Cr₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹4 Cr₹2 Cr
₹13 Cr₹10 Cr₹14 Cr₹12 Cr₹14 Cr₹16 Cr₹7 Cr
₹3 Cr-₹6 Cr-₹4 Cr-₹3 Cr-₹1 Cr₹6 Cr-₹6 Cr
₹116 Cr₹121 Cr₹128 Cr₹129 Cr₹65 Cr₹60 Cr₹54 Cr
₹43₹41₹40₹41₹16₹14₹9
₹43₹41₹40₹41₹16₹14₹9

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
₹4 Cr₹3 Cr-₹3 Cr₹3 Cr₹4 Cr₹1 Cr₹1 Cr
₹2 Cr₹2 Cr₹3 Cr₹6 Cr₹6 Cr₹7 Cr₹8 Cr
₹4 Cr₹3 Cr₹73 L-₹71 Cr₹4 Cr-₹10 Cr₹30 L
₹10 Cr₹8 Cr₹1 Cr-₹62 Cr₹15 Cr-₹69 L₹10 Cr
₹9 Cr₹7 Cr₹1 Cr-₹63 Cr₹15 Cr-₹96 L₹10 Cr
-₹1 Cr-₹63 L-₹7 L-₹2 Cr-₹8 Cr-₹24 L-₹31 L
-₹7 Cr-₹8 Cr₹1 Cr₹63 Cr-₹8 Cr₹4 Cr-₹9 Cr
₹61 L-₹1 Cr₹2 Cr-₹2 Cr-₹1 Cr₹3 Cr₹51 L
₹2 Cr₹3 Cr₹1 Cr₹3 Cr₹4 Cr₹1 Cr₹90 L
₹3 Cr₹2 Cr₹3 Cr₹1 Cr₹3 Cr₹4 Cr₹1 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)0.00
Volume (₹)0.00
High (₹)0.00
Upper Circuit101.82
Low (₹)0.00
Lower Circuit67.88
Prev Close84.85
52W High (₹)99.50
Price84.85
52W Low (₹)59.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)198.55 Cr
Div. Yield (%)0.00
PE Ratio59.45
Debt to Equity0.13
Price to Book2.40
Book Value42.60
EPS (TTM)1.43
Face Value10.00
ROE (%)3.34

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
APOLLOHOSP-ANSE
MAXHEALTH-ANSE
FORTIS-ANSE
ASTERDM-ANSE
NH-ANSE
MEDANTA-ANSE
LALPATHLAB-ANSE
KIMS-ANSE
AGARWALEYE-ANSE
VIJAYA-ANSE
AASHKA-MNSE
LTP
1W Low
1W High
Market cap (₹)
8666.8-178.9 (-2.02%)
8640.15
8900.90
1,26,300Cr
990.5-22.55 (-2.23%)
985.30
1025
96,763Cr
911.95-18.05 (-1.94%)
893.30
928.80
68,901Cr
789.8+44.65 (5.99%)
745.55
791.55
68,592Cr
1866.55-65.1 (-3.37%)
1861.90
1949.20
38,439Cr
1482.8+12.3 (0.84%)
1411
1500
38,149Cr
1876-54.7 (-2.83%)
1854.40
1961.20
32,259Cr
765.3-4.5 (-0.58%)
748.30
778.15
32,231Cr
510.2+2.5 (0.49%)
502.60
524.70
16,249Cr
1494.45+42.65 (2.94%)
1451.85
1529.65
15,511Cr
84.85+10.35 (13.89%)
67
87
199Cr

Aashka Hospitals Ltd Annual Results Key Takeaways

Basis: Consolidated annual results.

Aashka Hospitals Ltd Quaterly Results Key Takeaways